Why would one hormone need two separate receptors?
Melatonin is released on a daily rhythm, and the SCN is packed with receptors for it. If melatonin only did one thing, a single receptor type would be enough. Instead, the SCN carries two, MT1 and MT2, and studies of the clock describe two distinct responses to melatonin: firing slows down, and the timing of the clock's rhythm shifts [1]. The simplest reading is that the two receptors divide the labor, with MT1 handling the acute inhibition of neuronal activity and MT2 handling the phase shift [1][2].
This division makes practical sense for a clock. A signal that quiets neurons is useful for a short window, such as consolidating a rest period, while a signal that moves the phase of the rhythm changes when the clock thinks it is. The evidence supports that these are separate actions tied to separate receptors, though the studies describe the division of roles rather than proving why the system is built this way [1][2].
What acute inhibition looks like at the neuron level
Acute inhibition means the SCN neurons fire less often, and it happens while melatonin is present. In the SCN, MT1 is the receptor linked to this inhibitory effect on neuronal firing [1][2]. The change is in the moment-to-moment activity of the cells, not in the underlying timing of the clock, which is why it is described as an acute effect rather than a resetting one [1].
This is the kind of response you would expect from a brake rather than a steering wheel. The neurons keep their rhythm, but their output is dampened while the signal lasts. The evidence ties this dampening specifically to MT1, separating it from the phase-shifting action that involves MT2 [1][2].
What a clock phase shift looks like, and why MT2 is involved
A phase shift is different from a change in firing rate. It means the clock's rhythm moves earlier or later, so the same pattern of activity occurs at a different time. In the SCN, MT2 is the receptor implicated in this phase-shifting effect on circadian firing rhythms [1][2]. The shift is a change in timing, not just a change in how strongly the neurons fire.
The two effects can therefore be told apart by what changes: firing rate for MT1, and the phase of the rhythm for MT2 [1][2]. Studies of melatonin receptor knockout mice add a supporting observation: when a receptor is removed, the phase-shifting response to melatonin is blunted while the inhibitory effect on SCN firing is also affected, which is consistent with the two responses being separable [3]. That knockout work does not by itself assign each effect to MT1 versus MT2, so the receptor-specific assignment rests on the studies that directly compare the two [1][2].
How firm is the MT1-versus-MT2 split?
The split is stated directly in reviews of melatonin receptor function, which describe MT1 as inhibiting neuronal activity and MT2 as inducing phase shifts in the SCN [1]. Molecular work on the SCN reaches the same conclusion, with MT1 mediating acute neuronal inhibition and MT2 implicated in phase shifts [2]. The two lines of evidence agree on the division of labor.
What the evidence does not do is spell out the full chain from receptor to cellular effect in everyday terms. The studies establish which receptor is tied to which response, and the knockout observations are consistent with separable responses, but the mechanistic details beyond that assignment are not laid out in these sources [1][2][3]. For a general reader, the useful takeaway is the pairing itself: MT1 for the fast quieting of clock neurons, MT2 for moving the clock's timing.
Sources used in this answer
Melatonin receptors: role on sleep and circadian rhythm regulation
MT1 receptors inhibit neuronal activity while MT2 receptors induce phase shifts in circadian firing rhythms in the SCN.
Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock
MT1 mediates acute neuronal inhibition and MT2 is implicated in phase shifts of the SCN circadian clock.
Essay: Rhythmic melatonin release controlled by the SCN and its consequences for glucose homeostasis
In melatonin receptor knockout mice, the phase-shifting response to melatonin was blunted and the inhibitory effect on SCN firing was affected, consistent with separable inhibitory and phase-shifting responses.
